KIF18A INHIBITORS

as defined herein, and synthetic intermediates thereof, which are capable of modulating KIF18A protein thereby influencing the process of cell cycle and cell proliferation to treat cancer and cancer-related diseases. The invention also includes pharmaceutical compositions, including the compounds, a...

Full description

Saved in:
Bibliographic Details
Main Authors BANERJEE, Abhisek, FROHN, Michael J, LOW, Jonathan Dante, CHEN, Jian Jeffrey, MINATTI, Ana Elena, BROWN, James Alexander, BOURBEAU, Matthew Paul, LI, Kexue, JIA, Lei, PETTUS, Liping H, WALTON, Mary Catherine, MA, Vu, TAMAYO, Nuria A, LIU, Qingyian
Format Patent
LanguageEnglish
Published 30.07.2020
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
METALLURGY
ORGANIC CHEMISTRY
Online AccessGet full text

Cover

More Information
Summary:as defined herein, and synthetic intermediates thereof, which are capable of modulating KIF18A protein thereby influencing the process of cell cycle and cell proliferation to treat cancer and cancer-related diseases. The invention also includes pharmaceutical compositions, including the compounds, and methods of treating disease states related to the activity of KIF18A.
Bibliography:Application Number: US201916724119